NO20033683L - 2,4-disubstituerte pyrimidin-5-karboksamidderivater som KCNQ kaliumkanal modulatorer - Google Patents
2,4-disubstituerte pyrimidin-5-karboksamidderivater som KCNQ kaliumkanal modulatorerInfo
- Publication number
- NO20033683L NO20033683L NO20033683A NO20033683A NO20033683L NO 20033683 L NO20033683 L NO 20033683L NO 20033683 A NO20033683 A NO 20033683A NO 20033683 A NO20033683 A NO 20033683A NO 20033683 L NO20033683 L NO 20033683L
- Authority
- NO
- Norway
- Prior art keywords
- potassium channel
- channel modulators
- carboxamide derivatives
- kcnq potassium
- disubstituted pyrimidine
- Prior art date
Links
- 102000012359 KCNQ Potassium Channels Human genes 0.000 title 1
- 108010022282 KCNQ Potassium Channels Proteins 0.000 title 1
- QDXGKRWDQCEABB-UHFFFAOYSA-N pyrimidine-5-carboxamide Chemical class NC(=O)C1=CN=CN=C1 QDXGKRWDQCEABB-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26980001P | 2001-02-20 | 2001-02-20 | |
| PCT/US2002/004305 WO2002066036A1 (fr) | 2001-02-20 | 2002-02-14 | Derives de 2,4-disubstitue pyrimidine-5-carboxamide en tant que modulateur des canaux potassium kcnq |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20033683D0 NO20033683D0 (no) | 2003-08-19 |
| NO20033683L true NO20033683L (no) | 2003-10-17 |
Family
ID=23028698
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20033683A NO20033683L (no) | 2001-02-20 | 2003-08-19 | 2,4-disubstituerte pyrimidin-5-karboksamidderivater som KCNQ kaliumkanal modulatorer |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20020183335A1 (fr) |
| EP (1) | EP1361879A1 (fr) |
| JP (1) | JP2005508833A (fr) |
| CA (1) | CA2438231A1 (fr) |
| CZ (1) | CZ20032233A3 (fr) |
| HU (1) | HUP0303841A2 (fr) |
| MX (1) | MXPA03007395A (fr) |
| NO (1) | NO20033683L (fr) |
| PL (1) | PL372944A1 (fr) |
| WO (1) | WO2002066036A1 (fr) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1453516A2 (fr) | 2001-10-17 | 2004-09-08 | Boehringer Ingelheim Pharma GmbH & Co.KG | Nouvelles pyrimidines substituees, procede permettant de les produire et leur utilisation comme medicament |
| UY27487A1 (es) | 2001-10-17 | 2003-05-30 | Boehringer Ingelheim Pharma | Derivados de pirimidina, medicamentos que contienen estos compuestos, su empleo y procedimiento para su preparación |
| US7205307B2 (en) | 2002-02-14 | 2007-04-17 | Icagen, Inc. | Pyrimidines as novel openers of potassium ion channels |
| US7176310B1 (en) * | 2002-04-09 | 2007-02-13 | Ucb Sa | Pyrimidinecarboxamide derivatives and their use as anti-inflammatory agents |
| DE60308699T2 (de) * | 2002-08-21 | 2007-08-23 | Glaxo Group Ltd., Greenford | 2-phenylamino-4-trifluoromethyl-5-(benzyl- oder pyridin-4-ylmethyl)carbamoylpyrimidin-derivate als selektive cb2 cannabinoid-rezeptor modulatoren |
| UY27939A1 (es) | 2002-08-21 | 2004-03-31 | Glaxo Group Ltd | Compuestos |
| US7459460B2 (en) * | 2003-05-28 | 2008-12-02 | Bristol-Myers Squibb Company | Trisubstituted heteroaromatic compounds as calcium sensing receptor modulators |
| US7816529B2 (en) * | 2003-07-02 | 2010-10-19 | Vertex Pharmaceuticals Incorporated | Pyrimidines useful as modulators of voltage-gated ion channels |
| KR20060123403A (ko) * | 2003-12-01 | 2006-12-01 | 쿠도스 파마슈티칼스 리미티드 | 암 치료를 위한 ｄｎａ 손상 수복 억제제 |
| GB0402356D0 (en) * | 2004-02-03 | 2004-03-10 | Glaxo Group Ltd | Novel compounds |
| GB0404105D0 (en) * | 2004-02-24 | 2004-03-31 | Glaxo Group Ltd | Novel compounds |
| TWI357901B (en) * | 2004-03-12 | 2012-02-11 | Lundbeck & Co As H | Substituted morpholine and thiomorpholine derivati |
| DE602005024382D1 (de) | 2004-04-13 | 2010-12-09 | Astellas Pharma Inc | Polycyclische pyrimidine als kaliumionenkanal-modulatoren |
| US7705042B2 (en) * | 2004-10-22 | 2010-04-27 | Janssen Pharmaceutica Nv | Class of arylamide compounds useful as inhibitors of c-fms kinase |
| JP2008519034A (ja) | 2004-11-03 | 2008-06-05 | バーテックス ファーマシューティカルズ インコーポレイテッド | イオンチャネル調節剤としてのピリミジン誘導体および使用方法 |
| UA92340C2 (en) * | 2005-03-03 | 2010-10-25 | Х. Луннбек А/С | Substituted pyridine derivatives |
| PL2298766T3 (pl) * | 2005-03-03 | 2014-09-30 | H Lundbeck As | Preparaty farmaceutyczne zawierające podstawione pochodne pirydyny |
| EP1863796A1 (fr) * | 2005-03-22 | 2007-12-12 | NeuroSearch A/S | Pyrazolyl-pyrimidines comme agents de modulation de la voie du potassium et leur utilisation medicale |
| DE102005038947A1 (de) | 2005-05-18 | 2006-11-30 | Grünenthal GmbH | Substituierte Benzo[d]isoxazol-3-yl-amin-Verbindungen und deren Verwendung in Arzneimitteln |
| WO2006130493A2 (fr) * | 2005-05-31 | 2006-12-07 | Vertex Pharmaceuticals Incorporated | Heterocycles utiles comme modulateurs de canaux ioniques |
| AU2006322461A1 (en) * | 2005-09-09 | 2007-06-14 | H. Lundbeck A/S | Pyrimidine derivatives and their use as KCNQ potassium channels openers |
| US7683058B2 (en) | 2005-09-09 | 2010-03-23 | H. Lundbeck A/S | Substituted pyrimidine derivatives |
| WO2008104869A1 (fr) | 2007-02-26 | 2008-09-04 | Pfizer Products Inc. | Composés hétérocycliques utiles dans le traitement de maladies et de conditions |
| EP2257539B1 (fr) | 2008-03-18 | 2014-09-10 | Merck Sharp & Dohme Corp. | 4-hydroxypyrimidine-5-carboxamides substitués |
| TWI504395B (zh) | 2009-03-10 | 2015-10-21 | Substituted 3-amino-2-mercaptoquinoline as a KCNQ2 / 3 modifier | |
| TWI475020B (zh) * | 2009-03-12 | 2015-03-01 | The substituted nicotine amide as a KCNQ2 / 3 modifier | |
| TWI461197B (zh) | 2009-03-12 | 2014-11-21 | 2-mercaptoquinoline-3-carboxamide as a KCNQ2 / 3 modifier | |
| TW201038565A (en) | 2009-03-12 | 2010-11-01 | Gruenenthal Gmbh | Substituted 2-mercapto-3-aminopyridines as KCNQ2/3 modulators |
| EP2590961A1 (fr) * | 2010-07-08 | 2013-05-15 | Pfizer Inc | Amides pipéridinyl pyrimidine en tant qu'ouvreurs du canal potassique ko7 |
| PE20131379A1 (es) | 2010-08-27 | 2013-11-29 | Gruenenthal Chemie | 2-oxi-quinolina-3-carboxamidas sustituidas como moduladores kcnq2/3 |
| AR082733A1 (es) | 2010-08-27 | 2012-12-26 | Gruenenthal Gmbh | 2-amino-quinolina-3-carboxamidas sustituidas como moduladores de kcnq2/3 |
| BR112013004690A2 (pt) | 2010-08-27 | 2016-05-10 | Gruenenthal Gmbh | 2-oxo-e 2-tioxo-di-hidroquinolina-3-carboxamidas substituídas como moduladores kcnq2/3 |
| US8618129B2 (en) | 2010-09-01 | 2013-12-31 | Gruenenthal Gmbh | Substituted 1-oxo-dihydroisoquinoline-3-carboxamides as KCNQ2/3 modulators |
| US9168259B2 (en) | 2010-10-20 | 2015-10-27 | Grünenthal GmbH | Substituted 6-amino-nicotinamides as KCNQ2/3 modulators |
| NZ610689A (en) | 2010-10-20 | 2014-08-29 | Gruenenthal Chemie | Substituted 6-amino-nicotinamides as kcnq2/3 modulators |
| EP2888233B1 (fr) * | 2012-04-18 | 2016-09-28 | Grünenthal GmbH | 6-amino-nicotinamides substitués comportant un groupe contenant de l'oh en tant que modulateurs kcnq2/3 |
| CA2870572A1 (fr) | 2012-04-18 | 2013-10-24 | Grunenthal Gmbh | 4-aminobenzamides substitues utilises comme modulateurs de kcnq2/3 |
| US9248122B2 (en) | 2012-11-28 | 2016-02-02 | Grünenthal GmbH | Heteroquinoline-3-carboxamides as KCNQ2/3 modulators |
| JP2016508118A (ja) * | 2012-11-28 | 2016-03-17 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | Ｋｃｎｑ２／３モジュレーターとしての置換アミノ−アリールカルボキサミド |
| MX2015006689A (es) | 2012-11-28 | 2015-08-20 | Grünenthal GmbH | Carboxamidas especificas como moduladores de kcnq2/3. |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5935966A (en) * | 1995-09-01 | 1999-08-10 | Signal Pharmaceuticals, Inc. | Pyrimidine carboxylates and related compounds and methods for treating inflammatory conditions |
| US5811428A (en) * | 1995-12-18 | 1998-09-22 | Signal Pharmaceuticals, Inc. | Pyrimidine carboxamides and related compounds and methods for treating inflammatory conditions |
| US5852028A (en) * | 1995-12-18 | 1998-12-22 | Signal Pharmaceuticals, Inc. | Pyrimidine carboxylates and related compounds and methods for treating inflammatory conditions |
| US6274588B1 (en) * | 1999-05-31 | 2001-08-14 | Hoffmann-La Roche Inc. | 4-phenyl-pyrimidine derivatives |
| CA2378243C (fr) * | 1999-08-04 | 2012-05-15 | Icagen, Inc. | Procedes therapeutiques ou prophylactiques de la douleur et de l'anxiete |
| US6855829B2 (en) * | 2001-02-20 | 2005-02-15 | Bristol-Myers Squibb Company | 3-fluoro-2-oxindole modulators of KCNQ potassium channels and use thereof in treating migraine and mechanistically related disease |
-
2002
- 2002-02-14 PL PL02372944A patent/PL372944A1/xx not_active Application Discontinuation
- 2002-02-14 CA CA002438231A patent/CA2438231A1/fr not_active Abandoned
- 2002-02-14 WO PCT/US2002/004305 patent/WO2002066036A1/fr not_active Ceased
- 2002-02-14 JP JP2002565594A patent/JP2005508833A/ja active Pending
- 2002-02-14 US US10/075,521 patent/US20020183335A1/en not_active Abandoned
- 2002-02-14 HU HU0303841A patent/HUP0303841A2/hu unknown
- 2002-02-14 EP EP02709517A patent/EP1361879A1/fr not_active Withdrawn
- 2002-02-14 MX MXPA03007395A patent/MXPA03007395A/es unknown
- 2002-02-14 CZ CZ20032233A patent/CZ20032233A3/cs unknown
-
2003
- 2003-08-19 NO NO20033683A patent/NO20033683L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PL372944A1 (en) | 2005-08-08 |
| NO20033683D0 (no) | 2003-08-19 |
| US20020183335A1 (en) | 2002-12-05 |
| JP2005508833A (ja) | 2005-04-07 |
| EP1361879A1 (fr) | 2003-11-19 |
| WO2002066036A1 (fr) | 2002-08-29 |
| MXPA03007395A (es) | 2003-12-04 |
| CA2438231A1 (fr) | 2002-08-29 |
| CZ20032233A3 (cs) | 2004-12-15 |
| HUP0303841A2 (hu) | 2004-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20033683D0 (no) | 2,4-disubstituerte pyrimidin-5-karboksamidderivater som KCNQ kaliumkanal modulatorer | |
| NO20012739D0 (no) | 3-substituerte-4-arylquinolin-2-on-derivater som kaliumkanal modulatorer | |
| DK1446394T3 (da) | Hidtil ukendte 1,2,4-thiadiazolderivater som melanocortinreceptormodulatorer | |
| DK1414803T3 (da) | Pyrazolylcarboxanilider som fungicider | |
| CY2014041I2 (el) | 2,3-διυδρο-6-νιτροϊμιδαζο 2,1 -b-οξαζολια | |
| NO20035245L (no) | Grunnleggende Wi-Fi-arkitektur for 802.11-nettverk | |
| NO20034930D0 (no) | Substituerte cykloheksan-1,4-diaminderivater | |
| NO20022649D0 (no) | Heterocykliske dihydropyrimidiner som kaliumkanal inhibitorer | |
| DK1593670T3 (da) | Hydroxysubstituerede 2-azetidinoner, der er anvendelige som hypokolesterolæmiske midler | |
| NO20052995D0 (no) | 1,5-diaryl-pyrrol-3-karboksamid-derivater, og deres anvendelse som kannabinoid reseptormodulatorer. | |
| ATE323706T1 (de) | Pyrazolopyridazinderivate | |
| NO20040632L (no) | 2-amino-4,5-trisubstituerte tiazolylderivater. | |
| NO20033353D0 (no) | Karotenoid biosyntese | |
| DK1429607T3 (da) | Delta-1-pyrroliner som pesticider | |
| DK1339685T3 (da) | Biphenylcarboxamider, der er egnede som lipidsænkende midler | |
| DE60210598D1 (de) | 3,7-DIAZABICYCLOc3.3.1Ü-FORMULIERUNGEN ALS ANTIARRHYTHMIKA | |
| NO20033234L (no) | Karotenoider som antihypertensjonsmidler | |
| NO20005570D0 (no) | Cyklopentanondihydropyridinforbindelser anvendbare som kaliumkanalÕpnere | |
| NO20044413L (no) | 1,2-Dihydropyrazol-3-oner som cytokinmediatorer | |
| DE60213084D1 (de) | 3,7-DIAZABICYCLOc3.3.1Ü-FORMULIERUNGEN ALS ANTIARRHYTHMIKA | |
| ITMI20022183A1 (it) | Cerniera. | |
| DK1349850T3 (da) | Natriumkanalmodulatorer, der er afledt af 2-piperidylimidazoler | |
| ITTO20020744A1 (it) | Composizione. | |
| DK1487802T3 (da) | 2,3-diaryl-pyrazolidin-derivater som neurotensin-nedbrydende enzyminhibitorer | |
| HK1057483A (en) | 2,4-disubstituted pyrimidine-5-carboxamide derivatives as kcnq potassium channel modulators |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |